• Return to Headlines

Shares of MACK Up 34.9% Since Uptrend Call on Shares

By James Quinn

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 2 months, Merrimack Pharma has returned 34.94% as of today's recent price of $6.70.

Merrimack Pharma share prices have moved between a 52-week high of $11.70 and a 52-week low of $3.34 and are now trading 101% above that low price at $6.73 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.8% while the 50-day MA has advanced 3.9%.

Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs for the treatment of immunological and autoimmune diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Merrimack Pharma shares.

Log in and add Merrimack Pharma (MACK) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights merrimack pharma

Ticker(s): MACK